{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":""},{"Key":"CEHoursPP8","Value":""},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":"NCI-NIH-Sponsored Session"},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"6"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":null,"ContentCaptureVendorSpecification":null,"Created":null,"Date":"2024-04-09","Description":"<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">The National Cancer Institute&#39;s (NCI&rsquo;s) Childhood Cancer Data Initiative (CCDI) has been at the forefront of advancing research and therapies for childhood and adolescent and young adult (AYA) cancers. This session&nbsp;serves as an essential update on the CCDI&#39;s ongoing efforts.&nbsp;<\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">CCDI encompasses a multi-faceted approach, and this session provides a comprehensive overview of some key components: <\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\"><i>Molecular Characterization Initiative (MCI): Updates on a Transformational Collaboration:&nbsp;<\/i><\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">Within CCDI, MCI plays a pivotal role in unraveling the molecular intricacies of pediatric and AYA cancers. By focusing on the genetic and molecular underpinnings of these diseases, MCI aims to pave the way for diagnostic accuracy, improved understanding of biology, and the development of more targeted and effective treatments.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\"><i>Developing a Framework for a CCDI Coordinated Pediatric and Young Adult Rare Cancer Initiative:&nbsp;<\/i><\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">Rare malignancies in children and AYAs present unique challenges due to their limited prevalence. CCDI recognizes the significance of addressing these rare tumors and is actively developing a framework to coordinate national efforts, thereby improving research and treatment options for these patients.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\"><i>CCDI Data Ecosystem Tools &amp; Resources<\/i>:&nbsp;<\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">Data are the cornerstone of cancer research and CCDI has been working diligently working to enhance its data ecosystem. This presentation will focus on resources available to researchers and stakeholders that enable them to access, analyze, and contribute to the wealth of CCDI data.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">Using Proteogenomic Approaches in Pediatric Brain Cancer Treatment, from Discovery to Clinical Trials:&nbsp;<\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">This collaboration between the Clinical Proteomic Tumor Analysis Consortium and the Children&#39;s Brain Tumor Network aims to incorporate proteogenomic methods into the treatment of pediatric brain cancer and may provide proof of concept for proteomic interrogation in other pediatric cancers.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">The overarching goal of this session is to foster collaboration and engagement within the national and international childhood and AYA cancer community. By sharing the latest progress highlights and developments, the CCDI aims to catalyze a collective effort to better understand these diseases. Through this understanding, the ultimate objective is to drive the development of more effective therapies, providing hope and improved outcomes for children and AYAs facing rare malignancies.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">Join us to stay informed and connected within the dynamic landscape of childhood cancer research and care. Together, we can make a meaningful impact on the lives of young patients and their families.<\/span><\/span><\/span><\/p>\u000a\u000a<p><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\"><b>Session Overview:&nbsp;<\/b><\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">This session will provide a broad overview of Childhood Cancer Data Initiative (CCDI) activities, including updates on the Molecular Characterization Initiative and developing a framework for the CCDI Coordinated Pediatric and Young Adult Rare Cancer Initiative, information on connecting with CCDI Data Ecosystem resources, and using proteogenomic approaches in pediatric brain cancer treatment.&nbsp;<\/span><\/span><\/span><span style=\"font-size:11pt\"><span style=\"line-height:normal\"><span style=\"font-family:Calibri,sans-serif\">The goal of this session is to engage the national and international childhood and adolescent and young adult (AYA) cancer community to advance the understanding of and, ultimately, improve therapies for children and AYAs with rare malignancies.<\/span><\/span><\/span><\/p>\u000a\u000a<p>&nbsp;<\/p>\u000a","Duration":60,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/9\/2024 3:30:00 PM","EndTime":"15:30","HidePresentationRating":"False","HidePresentations":"False","Id":"635","Key":"20ce7549-daa5-468a-8237-49db6286ab96","LastUpdated":"2024-03-07 22:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"Room 2 - Upper Level - Convention Center","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"NIH10","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Incomplete","SearchResultBody":"NIH10. Building on the Power of Data and Community","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"Room 2 - Upper Level - Convention Center","SearchResultHeader":"Apr  9 2024  2:30PM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/9\/2024 2:30:00 PM","StartTime":"14:30","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Building on the Power of Data and Community","Type":null,"TypeKey":null}